This study revealed a previously unrecognized role of SEMA3B in the pathogenesis of pulmonary fibrosis and provides critical insight into targeting the SEMA3B-NRP1 axis as a potential therapeutic option for pulmonary fibrosis. The gene discussed is NRP1; the disease is pulmonary fibrosis.